Tianhang Zhang – InmunoES

Impact of immune-related adverse events on treatment outcomes in advanced esophageal squamous cell carcinoma treated with immune checkpoint inhibitors

5 de February de 2026 by Tianhang Zhang

BackgroundWhile immune-related adverse events (irAEs) are associated with better prognosis in advanced esophageal squamous cell carcinoma (ESCC), the prognostic impact of single-organ irAE (uni-irAE), multiple-organ irAEs (multi-irAEs), and organ-speci…

The impact of immune-related adverse events on the outcome of advanced gastric cancer patients with immune checkpoint inhibitor treatment

24 de December de 2024 by Tianhang Zhang

BackgroundThe occurrence of immune-related adverse events (irAEs) seemed to be associated with better outcomes in advanced gastric cancer (AGC) patients. However, research focusing on the impact of the single-organ irAE (uni-irAE) or multi-organ irAEs …